FDA Inspection 1306552 - Ascendis Pharma LLC - March 06, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ascendis Pharma LLC

Record Details

This FDA Inspection record concerns Ascendis Pharma LLC, with an inspection on March 6, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Ascendis Pharma LLC
Inspection Date: March 6, 2026
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · 6d5dd80a-ac1f-44a2-9413-1a4318eb357b

Violation Codes2

21 CFR 314.80(c)(1)(i)21 CFR 600.80(b)

Full citation text and observation details available on the Dashboard.